Prospective, unmasked, evaluation of the iStent in patients that have primary open-angle glaucoma (OAG). Stent implantation in one eye will be used for analysis, with medication added at 6 months, as required.
One hundred patients will be enrolled in the study at up to 21 sites; follow-up is through 1 year.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
112
Glaukos iStent, medication
S.V. Malayan's Ophtalmology Centre
Yerevan, Armenia
Allgemeines Krankenhaus Wien
Vienna, Austria
Chu de Lyon Hospital Edouard Herriot
Lyon, France
IOP 18 mm Hg or less without medications
Time frame: At 6 months
IOP 18 mm Hg or less with or without medications
Time frame: 12 months
Mean IOP
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
CHNO des Quinze-Vingts
Paris, France
Hopital Saint-Joseph
Paris, France
Knapschaftskrankenhaus Bochum Langendreer
Bochum, Germany
Universitatsklinkum Erlangen
Erlangen, Germany
Universitatsklinikum Magdeburg A.o.R.
Magdeburg, Germany
Dietrich-Bonhoeffer-Klinikum Neubrandenburg
Neubrandenburg, Germany
Universita' degli Studi di Parma
Parma, Italy
...and 3 more locations